Navigation Links
Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results
Date:2/13/2009

SUNNYVALE, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today reported financial results for its second fiscal quarter ended December 31, 2008. The net loss for the second quarter of fiscal 2009 was $4.8 million, or $0.19 per share, compared to a net loss of $5.9 million, or $0.23 per share, in the second quarter of fiscal 2008.

Total operating expenses were $4.9 million in the second quarter of fiscal 2009, including $0.4 million of severance related share-based compensation expense and $0.2 million of cash severance expense. Excluding the $0.6 million of severance related expenses, total expenses were $4.3 million in the second quarter of fiscal 2009 compared to $6.2 million for the second quarter of fiscal 2008, a decrease of $1.9 million. Excluding $0.4 million in severance related share-based compensation expense, share-based compensation expense was $0.2 million in the second quarter of fiscal 2009 compared to $0.6 million in the second quarter of fiscal 2008. The decrease of $1.9 million in total operating expenses, after excluding the severance related expenses, in the second quarter of fiscal 2009 was primarily due to reduced personnel expenses due to lower headcount and reduced manufacturing costs and outside preclinical expenses associated with the company's HDAC, Btk and Factor VIIa inhibitor programs.

Pharmacyclics also reported its financial results for the six months ended December 31, 2008. The net loss for the six months ended December 31, 2008 was $11.4 million, or $0.44 per share, compared to a net loss of $12.7 million, or $0.49 per share, for the six months ended December 31, 2007. The net loss for the six months ended December 31, 2008 included $2.5 million of severance related expenses.

As of December 31, 2008, the Company's cash, cash equ
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth
2. Pharmacyclics Secures $5.0 Million in Debt Financing
3. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
4. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
5. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
6. Pharmacyclics Announces It Received Nasdaq Notification
7. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
8. YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
9. Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results
10. Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial Results
11. Corgenix Reports Second Quarter Fiscal 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 Kitware , ... announces a new Fast-Track award from the U.S. Department ... environment (IDAE) for the nuclear power industry. , Construction ... more than 30 years, but the United States’ nuclear ... gains in power plant utilization through improved refueling, maintenance, ...
(Date:6/17/2013)... Belvoir, VA (PRWEB) June 17, 2013 ... annual Basic Research Technical Review at the Waterford in ... More than 300 grant awardees will present technical details ... Technical sessions will cover a broad range of counter ... (2) Cognitive, Information and Network Science; (3) Science for ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 With the huge ... launch of the Chief Medical Officer Summit for Emerging Life ... will take place in San Francisco on November 4-5, 2013 ... the first time, West Coast Chief Medical Officers at biotechs ... Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive ...
(Date:6/17/2013)... June 17, 2013 ... announced the addition of the "North ... Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables ... Free & Auto Injectors] & Therapeutics- Forecasts ... ,      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
Breaking Biology Technology:Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review 2Chief Medical Officer Summit for Biotechs Goes West 2Chief Medical Officer Summit for Biotechs Goes West 3North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 2North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 3
... , , ... , , , ... analysis.,By comparing the separated bands,of an unknown sample to a ... fragment,can be estimated. The Agilent,2100 bioanalyzer is an instrument,which utilizes ...
... , , ... , , , Whereas in ... molecules, the development of soft ionization methods,such as matrix-assisted laser desorption/ionization ... the analysis of proteins up to 300 kDa using MS has,become ...
... , , , ... , , , , ... studying functional,assays requiring the transfection of small interfering RNA (siRNA),into a cell, ... given cell lines would be of great value.,Three to four siRNA sequences ...
Cached Biology Technology:High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 2High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 3High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 4High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 5Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 2Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 3Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 4Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 5siRNA transfection optimization,with the Agilent 2100 bioanalyzer 2siRNA transfection optimization,with the Agilent 2100 bioanalyzer 3siRNA transfection optimization,with the Agilent 2100 bioanalyzer 4siRNA transfection optimization,with the Agilent 2100 bioanalyzer 5siRNA transfection optimization,with the Agilent 2100 bioanalyzer 6siRNA transfection optimization,with the Agilent 2100 bioanalyzer 7
(Date:6/17/2013)... Patients in Vietnam and other locations with central nervous ... of a newly discovered virus, according to a study ... open-access journal of the American Society for Microbiology. Researchers ... percent of 642 patients with central nervous system infections ... percent of fecal samples from pigs and poultry, suggesting ...
(Date:6/17/2013)... kids eat their food may turn out to be just ... study out of St. Michael,s Hospital. , The study, ... significant association between poor eating habits in kids ages ... "bad" cholesterol, putting them at risk for cardiovascular disease ... Canadian Medical Association Journal today. , "We ...
(Date:6/17/2013)... of improving original foundations with more modern elements. Using ... Pittsburgh,s Kenneth P. Dietrich School of Arts and Sciences ... drug delivery, gas storage, and gas transport more efficient ... in the latest issue of the Journal of ... The recent work builds upon Pitt Associate Professor of ...
Breaking Biology News(10 mins):New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3Poor eating behaviors may put preschoolers at risk for later health problems 2'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
... circles that rural peasant activities are at odds ... In fact, the opposite is often true, argue ... Perfecto. , Combining case studies with ecological ... farming practices encouraged by grassroots movements such as ...
... mechanism that regulates how many new cells are produced ... in the latest issue of the prestigious scientific journal, ... for things like neurological disorders and anaemia," says Professor ... old cells are continually being replaced by new. If ...
... reaching age 90 with preserved cognition, according to a ... Journal of Geriatric Psychiatry. The study, which was conducted ... to identify genetic links to cognitive longevity. , "Successful ... focused on individuals who had reached at least 90 ...
Cached Biology News:Agriculture and tropical conservation: rethinking old ideas 2Agriculture and tropical conservation: rethinking old ideas 3New stem-cell findings can help the body to cure itself 2New research examines genetics of successful aging 2
... 50mM Tris-HCl, pH 7.5, 0.1mM ... 1mM benzamidine, 0.1% 2-mercaptoethanol and ... Phosphatase 2A1) partially purified enzyme ... QSepharose,amino-hexyl agarose, Superdex 200, and ...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
...
... Anti-HMGN2/HMG-17 Immunogen : Recombinant ... pH7.4, 5mg/ml BSA, 0.15M NaCl, ... addition of glycerol to 30% ... immunoblot on acid extracts of ...
Biology Products: